Abstract
This study deals with the effects of freeze dried rhizome powder of Curcuma longa (C. longa) dissolved in milk on normal as well as diabetic models. Diabetes of type II and type I was within 3 days of a single administration of doses of 45 and 65 mg kg−1 of streptozotocin respectively. Various parameters such as blood glucose levels, triglycerides, total cholesterol, high density lipoprotein, very low density lipoprotein, low density lipoprotein, serum glutamic oxaloacetic transaminase, serum glutamic pyruvate transaminase, alkaline phosphatase, creatinine, hemoglobin, urine protein and urine sugar in addition to body weight were taken in to consideration and were analyzed after administration of variable doses of rhizome powder. The dose of 200 mg kg−1 was identified as the most effective dose as it increased HDL, Hb and bw (P<0.05) with significant decrease in the levels of blood glucose, lipid profile and hepatoprotective enzymes (P<0.001).
Key Words: Curcuma longa rhizome, Freeze dried, Antidiabetic, Hypolipidemic, Hepatoprotective
Full Text
The Full Text of this article is available as a PDF (143.7 KB).
References
- 1.Marles R.J., Fransworth N.R. Antidiabetic plants and their active constituents. Phytomedicine. 1995;2:137–189. doi: 10.1016/S0944-7113(11)80059-0. [DOI] [PubMed] [Google Scholar]
- 2.Irrova M.D., Paya M., Villar A. A review of natural products and plants as potential antidiabetic drugs. J Ethnopharmacol. 1989;27:243–275. doi: 10.1016/0378-8741(89)90001-9. [DOI] [PubMed] [Google Scholar]
- 3.Rai P.K., Jiaswal D., Diwakar S., Watal G. Antihyperglycemic Profile of Trichosanthes dioica Seeds in Experimental Models. Pharm Biol. 2008;46(5):1–6. doi: 10.1080/13880200801888011. [DOI] [Google Scholar]
- 4.Singh S.K., Kesari A.N., Gupta R.K., Jaiswal D., Watal G. Assessment of antidiabetic potential of Cynodon dactylon extract in streptozotocin diabetic rats. J Ethnopharmacol. 2007;114:174–179. doi: 10.1016/j.jep.2007.07.039. [DOI] [PubMed] [Google Scholar]
- 5.Ammon H.P.T., Wahal M.A. Pharmacology of Curcuma longa. Planta Medica. 1991;57:1–7. doi: 10.1055/s-2006-960004. [DOI] [PubMed] [Google Scholar]
- 6.Eigner D., Scholz D. Ferula asa-foetida and Curcuma longa in traditional medicine treatment and diet in Nepal. J Ethnopharmacol. 1999;67:1–6. doi: 10.1016/S0378-8741(98)00234-7. [DOI] [PubMed] [Google Scholar]
- 7.Eshrat H., Hussain M.A.L.I. Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn and partially purified product from Abroma augusta, Linn. In Streptozotocin induced diabetes. Ind J Clin Biochem. 2002;17:33–43. doi: 10.1007/BF02867969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Davidson M.B. Diabtes Mellitus, Diagnosis and Treatment. New York: Wiley; 1981. pp. 27–157. [Google Scholar]
- 9.Rai P.K., Rai N.K., Rai A.K., Watal G. Role of LIBS in elemental analysis of P. guajava responsible for glycemic potential. Inst Sc Tech. 2007;35(5):507–522. doi: 10.1080/10739140701540230. [DOI] [Google Scholar]
- 10.Maghrani M., Zeggwagh N.A., Lemhadri A., Amraoui M., Michel J.B., Eddouks M. Study of the hypoglycaemic activity of Fraxinus excelsior and Silybum marianum in an animal model of type 1 diabetes mellitus. J Ethnopharmacol. 2004;91:309–316. doi: 10.1016/j.jep.2004.01.008. [DOI] [PubMed] [Google Scholar]
- 11.Burcelin R., Rodriguez-gabin A.G., Charron M.J., Almazan G., Larocca J.N. Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1. Metabolism. 1999;48:252–258. doi: 10.1016/S0026-0495(99)90043-4. [DOI] [PubMed] [Google Scholar]
- 12.Brahm D., Trinder P. Estimation of glucose by glucose oxidase method. Analyst. 1972;97:142–145. doi: 10.1039/an9729700142. [DOI] [PubMed] [Google Scholar]
- 13.Alian C.C., Poon L.S., Chan C.S., Richmond W.F.U. Enzymatic determination of total cholesterols. Clin Chem. 1974;20:470–475. [PubMed] [Google Scholar]
- 14.Buccolo G., David M. Quantitative determination of Serum Triglycerides by use of enzyme. Clin Chem. 1973;19:476–482. [PubMed] [Google Scholar]
- 15.Henry R.J., Canon D.C., Winkelman J.W. Clinical Chemistry Principals and Techniques. 2nd edn. New York: Harper and Row; 1974. [Google Scholar]
- 16.Hansman T.U. Expert Panel of the IFCC on enzymes. Clin Chem Acta Clin Biochem. 1976;70:19. [Google Scholar]
- 17.Stricklad R.D., Freeman M.L., Gurule F.F. Copper binding by proteins in Alkaline solution. Analytical Chem. 1961;33:125–128. doi: 10.1021/ac60169a040. [DOI] [Google Scholar]
- 18.Gambino S.R., Meites S. Standard methods of Clinical Chemistry. 1965;5:55. [Google Scholar]
- 19.Nonfon M., Lieb F., Moeschler H., Wendish D. Four anonins from Annona squamosa. Phytochem. 1990;29:1951–1954. doi: 10.1016/0031-9422(90)85046-I. [DOI] [Google Scholar]
- 20.Friedwald W.T., Ley R.I., Fradrickson D.S. Estimation of low-density lipoprotein cholesterol in plasma without the use of preparative ultracentrifuge. Clin Chem. 1972;18:499–502. [PubMed] [Google Scholar]
- 21.Tsiani E., Bogdanovic E., Sorisky A., Nagy L., Fantus I.G. Tyrosine phosphatase inhibitors, vanadate and pervanadate, stimulate glucose transport and GLUT translocation in muscle cells by a mechanism independent of phosphatidylinositol 3-kinase and protein kinase C. Diabetes. 1998;47:1676–1686. doi: 10.2337/diabetes.47.11.1676. [DOI] [PubMed] [Google Scholar]
- 22.Eyrich M., Croner T., Leiler C., Lang P., Bader P., Klingebiel T., Niethammer D., Paul G. Distinct contributions of CD4+ and CD8+ naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors. Blood. 2002;100:1915–1918. doi: 10.1182/blood-2001-11-0005. [DOI] [PubMed] [Google Scholar]
- 23.Horwitz M.S., Bradley L.M., Harbertson J.K., Jael N.S. Diabetes induced by Coxsackie virus: Initiation by bystander damage and not molecular mimicry. Nature Medicine. 1998;4:781–785. doi: 10.1038/nm0798-781. [DOI] [PubMed] [Google Scholar]
- 24.Blondel O., Bailbe D., Portha B. In vivo insulin resistance in streptozotocin-diabetic rats -evidence for reversal following oral vanadate treatment. Diabetologia. 1989;32:185–190. doi: 10.1007/BF00265092. [DOI] [PubMed] [Google Scholar]
- 25.Hofteizer V. Comparison of streptozotocin-induced diabetes in the rat inducing volumetric quantitation of the pancreatic islets. Diabetologia. 1973;9:178–184. doi: 10.1007/BF01219780. [DOI] [PubMed] [Google Scholar]
- 26.Goodman L.S., Gilman A. The Pharmacological Basis of Therapeutics. 7th ed. New York: Macmillan; 1985. pp. 1490–1510. [Google Scholar]
- 27.Rhoads G.G., Gulbrandse C.L., KAGEN A Serum lipoprotein and coronary artery disease in a population study of Hawaiian Japanese men. N Eng J Med. 1976;294:293–298. doi: 10.1056/NEJM197602052940601. [DOI] [PubMed] [Google Scholar]
- 28.Zhang N., Ping Q.N., Huang G., Wen F.X.U. Investigation of lectinmodified insulin liposomes as carriers for oral administration. Int J Pharmaceuticals. 2006;194:147–259. [Google Scholar]
- 29.Batran A.S., Omer M.E., Salam A., Salwa M., Nofal R.B. Effect of rosiglytazone and Nateglinide on serum glucose and lipoid profile alone or in combination with the biguanide metformin in diabetic rats. Pharmacol Res. 2006;53:69–74. doi: 10.1016/j.phrs.2005.08.008. [DOI] [PubMed] [Google Scholar]
- 30.Olivarius D.N., Andresen H., Anne E.V., Holstein-rathlou N.H., Jorgensen G.M., Mogensen C.E. Urinary creatinine concentration is inversely related to glycemic control and the presence of some diabetic complications in patents with newly diagnosed Type 2 diabetes. J Diabetes and its Complications. 2006;20:45–50. doi: 10.1016/j.jdiacomp.2005.05.010. [DOI] [PubMed] [Google Scholar]